Tue 1 Dec 2009 | 14:27 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Anadys Pharmaceuticals, Inc.

Anadys Pharmaceuticals, Inc. (ANDS.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View ANDS on other exchanges
As of  2:09pm EST
2.33USD
Price Change
+0.04
Percent Change
+1.75%
 
Research Another Stock: Symbol Look-up

Name Total Annual Compensation Long-Term Incentive Plans All Other Fiscal Year Total
As Of 30 Dec 2008
Foletta, Mark -- -- -- --
Fotiadis, Marios -- -- -- --
Freddo, James 391,250 -- 310,738 701,988
Holtzman, Steven -- -- -- --
Papadopoulos, Stelios -- -- -- --
Reed, Elizabeth 230,000 -- 232,280 462,280
Scangos, George -- -- -- --
Slover, Peter -- -- -- --
Worland, Stephen 390,000 -- 604,029 994,029
Xanthopoulos, Kleanthis 581,000 -- 2,959,210 3,540,210